Tag: life sciences
-
Phone App Found to Measure Heart Health Metrics
A medical engineering team designed a smartphone app that in a clinical study shows it can measure key factors in heart health as accurately as MRI scans.
-
Field Tests of Genetically Modified Moths to Begin
Outdoor tests of a genetically engineered diamondback moth, a difficult agricultural pest, altered to stop reproducing and collapse the species, are about to get underway.
-
Engineered T-Cell Trials Stopped after Patient Death
The Food and Drug Administration stopped two clinical trials testing genetically engineered T-cells from the immune system to treat leukemia, after a participant in one trial died.
-
Trial Underway Testing Alzheimer’s-Schizophrenia Drug
A new clinical trial began in the U.K. in a test of an experimental drug to treat schizophrenia associated with Alzheimer’s disease.
-
Simple Cell Programming Designed for Gene Therapies
A simpler technique using nanoscale particles was shown in lab tests to deliver messenger RNA to reprogram cells for gene therapies, including changes in T-cells in the immune system now approved to treat a type of leukemia.
-
Trial Shows Smartphone App Finds More Heart Disease
Results from a clinical trial show an electrocardiogram app on a smartphone detects more cases of irregular heart beats than routine office visits.
-
Students Win Prize, Start Company for Alzheimer’s Detection
A team of undergraduate students won first prize in a National Institutes of Health biomedical engineering contest for a headset device to diagnose early-stage Alzheimer’s disease.
-
App Screens for Liver Diseases with Eye Selfies
A computer science lab designed a smartphone app that detects tell-tale indicators of liver disease and pancreatic cancer by analyzing self-taken photos of a patient’s own eyes.
-
Trial Testing Nicotine Patch for Lung Inflammation
A clinical trial is underway testing a nicotine patch worn to help stop smoking as a treatment for a chronic inflammatory disease affecting the lungs.
-
Engineered T-Cell Company Acquired for $11.9 Billion
A company developing personal cancer therapies that genetically engineer a patient’s immune system cells is being acquired in a deal valued at $11.9 billion.